Vogel Ashley N, Goldsmith Barbara M, Marzinke Mark A, Sokoll Lori J, Stickle Douglas F
Department of Pathology, Jefferson University Hospitals, Philadelphia, PA, United States.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Clin Biochem. 2016 Jan;49(1-2):176-9. doi: 10.1016/j.clinbiochem.2015.10.002. Epub 2015 Oct 22.
Interpatient distribution data for lipase (Roche Cobas® assay) showed an unexpected data gap, where no results were reported. This gap occurred beginning at a point just above the assay's primary measurement range (i.e., above the cutoff (300U/L) for automated repeat-on-dilution). Calculation or other errors within the automated dilution process were ruled out. Linearity of assay results was investigated.
Linearity of experimental sample dilution series data was assessed by correlation coefficient, intercept, and constancy of slope.
Dilution experiment data demonstrated a discontinuity of results between 300 and 400U/L consistent with the observed gap in patient data. Although data within the presumed linear range of the assay had a high linear correlation coefficient (r2>0.99), a non-zero intercept and progressively variable slope were inconsistent with linearity. Although the assay was assessed as linear by the College of American Pathology linearity survey, survey data also demonstrated non-linearity for this assay when analyzed for slopes and intercept.
Non-linearity in the presumed linear range of an assay can produce gaps in patient data above a repeat-on-dilution cutoff. As in this instance, CAP linearity surveys may not identify certain forms of non-linearity.